This opportunity is no longer accepting applications.
grant PAR-23-102

Mood and Psychosis Symptoms during the Menopause Transition (R21 Clinical Trial Optional)

This grant opportunity seeks to fund research on mood and psychotic disorders, such as depression, anxiety, bipolar disorder, and schizophrenia, specifically during the menopause transition. The goal is to identify targets for new treatment interventions by understanding the neurobiological and behavioral mechanisms involved. It encourages interdisciplinary collaboration to study how reproduct…

Reissue of RFA-MH-21-106 The purpose of this FOA is to advance translational research to better understand the emergence and worsening of mood and psychotic disorders (e.g., perimenopausal depression (PMD), generalized anxiety disorder, bipolar disorder and schizophrenia) during the menopause tr…

Funding Source

Agency: National Institutes of Health
Sub-agency: National Institute of Mental Health
Program: SBIR

Dates

Opportunity Released: January 13, 2023
Open for Submission: January 13, 2023
Submission Deadline: January 7, 2025
Application Window Closes: January 7, 2025

Supporting links

Secure Grant Funding 10x Faster

Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.

Already have an account? Sign In

Trusted by 500+ Happy Customers

Get opportunities sent to your inbox

The latest grant news and insights from our experts.

Save this opportunity and explore more

Share Opportunity

Share this opportunity with others.
Anyone with this link can view the opportunity details.